Skip to main content
. 2022 Apr 24;14(9):2123. doi: 10.3390/cancers14092123

Figure 5.

Figure 5

Overall survival of melanoma patients with and without brain metastases (A) and normal and elevated LDH level (B) since initiation of second line immunotherapy.